Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07424469 · ClinicalTrials.gov registry record · NA

Foregut Leaks-Role of Microbiome

A NA study of Gastrointestinal Diseases, sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07424469 is a NA study of Gastrointestinal Diseases that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 50 participants, below the 36,413-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07424469, a NA study of Gastrointestinal Diseases, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Aims 1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes

Conditions Studied

Interventions

  • OTHER Biopsy and fluid samples

Study Locations (1)

Texas

  • Baylor Scott & White Center for Advanced Surgery - Dallas

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-08-14
Est. Completion 2028-06-01
Phase NA

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT07424469

The ClinicalTrials.gov registry entry for NCT07424469 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,413-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastrointestinal Diseases appearing as the primary indexed condition, and to 1 intervention - of which Biopsy and fluid samples is the first listed.

NCT07424469 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07424469 about?

NCT07424469 is a clinical study titled "Foregut Leaks-Role of Microbiome". Aims 1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes

What is the current status of trial NCT07424469?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2020-08-14. Estimated completion is 2028-06-01.

What conditions does trial NCT07424469 study?

This clinical trial studies the following conditions: Gastrointestinal Diseases.

What interventions are being tested in trial NCT07424469?

The interventions under investigation include: Biopsy and fluid samples (OTHER).

Who is sponsoring clinical trial NCT07424469?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07424469 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.